Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00142194 · ClinicalTrials.gov registry record

Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation

A clinical trial, sponsored by Emory University.

Completed
Registry status
47
Enrollment target

NCT00142194: Completed study, sponsored by Emory University.

NCT00142194 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00142194 has completed, sponsored by Emory University.

COMPLETED
Registry status
47 participants
Enrollment target

Study Summary

Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated. In general, treatments are not very effective, with frequent relapses of the abnormal heart beats. One explanation for the high relapse rate is that the treatments might not address the underlying cause of atrial fibrillation. Recently, the investigators have found that atrial fibrillation is associated with increased oxidative stress. This is a condition where abnormal oxygen forms are produced. These forms harm the cells of the heart, causing them to beat abnormally. The investigators have found increased oxidative stress in pig and mouse models of atrial fibrillation. They would like to see if oxidative stress is present in humans with atrial fibrillation. In this study, they will compare blood markers of oxidative stress between patients with and without atrial fibrillation. It is the expectation that participants with atrial fibrillation will have more abnormal blood markers of atrial fibrillation. This study requires participants to visit their doctors, undergo a history and physical examination, and give blood only once.

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2005-06
Est. Completion 2007-11
Emory University

1,208 total trials

What the finished NCT00142194 record still lists

NCT00142194 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00142194 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00142194 about?

NCT00142194 is a clinical study titled "Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation". Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated. In general, treatments are not very effective, with frequent relapses of the abnormal heart beats. One explanation for the high relapse rate is that the treatments m...

What is the current status of trial NCT00142194?

This trial is currently completed. The enrollment target is 47 participants. The study started on 2005-06. Estimated completion is 2007-11.

Who is sponsoring clinical trial NCT00142194?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00142194, the US trial registry maintained by the National Library of Medicine. NCT00142194 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.